Updated:
Origin Partners
Origin Partners is a venture capital firm investing in information technologies, communications, and medical technologies. They have made 30 investments,...
Overview
Origin Partners is a venture capital firm investing in information technologies, communications, and medical technologies. They have made 30 investments, including Exsulin in 2012. Portfolio exits include Venafi in 2024, among nine total exits.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
North America
Country
United States
City
Hillsborough
Corporate office
Hillsborough, CA, United States
Frequently asked questions
Does Origin Partners have a disclosed sector focus?
No sector specialization has been publicly disclosed by Origin Partners. The firm's Hillsborough location and generalist venture mandate suggest exposure to the technology and innovation sectors typical of Bay Area private equity firms, but there is no confirmable public record of specific industry concentration or explicit exclusions.
Who runs investment decisions at Origin Partners?
Origin Partners has not publicly named its principals, investment committee members, or key decision-makers on its website or in available public records. The absence of disclosed leadership makes it impossible to identify who originates, evaluates, or approves investments at the firm.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: